The Role of Tetrahydrobiopterin and Dihydrobiopterin in Ischemia/Reperfusion Injury When Given at Reperfusion

被引:8
作者
Chen, Qian [1 ]
Kim, Elizabeth Eun Jung [1 ]
Elio, Katrina [1 ]
Zambrano, Christopher [1 ]
Krass, Samuel [1 ]
Teng, Jane Chun-wen [1 ]
Kay, Helen [1 ]
Perkins, Kerry-Anne [1 ]
Pershad, Sailesh [1 ]
McGraw, Sloane [1 ]
Emrich, Jeffrey [1 ]
Adams, Jovan S. [1 ]
Young, Lindon H. [1 ]
机构
[1] Philadelphia Coll Osteopath Med, Dept Pathol Microbiol & Immunol Forens Med, 4170 City Ave, Philadelphia, PA 19131 USA
关键词
D O I
10.1155/2010/963914
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Reduced nitric oxide (NO) bioavailability and increased oxidative stress are major factors mediating ischemia/reperfusion (I/R) injury. Tetrahydrobiopterin (BH4) is an essential cofactor of endothelial NO synthase (eNOS) to produce NO, whereas dihydrobiopterin (BH2) can shift the eNOS product profile from NO to superoxide, which is further converted to hydrogen peroxide (H2O2) and cause I/R injury. The effects of BH4 and BH2 on oxidative stress and postreperfused cardiac functions were examined in ex vivo myocardial and in vivo femoral I (20 min)/R (45 min) models. In femoral I/R, BH4 increased NO and decreased H2O2 releases relative to saline control, and these effects correlated with improved postreperfused cardiac function. By contrast, BH2 decreased NO release relative to the saline control, but increased H2O2 release similar to the saline control, and these effects correlated with compromised postreperfused cardiac function. In conclusion, these results suggest that promoting eNOS coupling to produce NO and decrease H2O2 may be a key mechanism to restore postreperfused organ function during early reperfusion.
引用
收藏
页数:11
相关论文
共 26 条
[1]   Ratio of 5,6,7,8- tetrahydrobiopterin to 7,8- dihydrobiopterin in endothelial cells determines glucose- elicited changes in NO vs. superoxide production by eNOS (vol 294, H1530, 2008) [J].
Crabtree, M. J. ;
Smith, C. L. ;
Lam, G. ;
Goligorsky, M. S. ;
Gross, S. S. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2010, 299 (02) :H576-H576
[2]   ENDOTHELIAL AND MYOCARDIAL INJURY DURING ISCHEMIA AND REPERFUSION - PATHOGENESIS AND THERAPEUTIC IMPLICATIONS [J].
FORMAN, MB ;
PUETT, DW ;
VIRMANI, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 13 (02) :450-459
[3]   Direct measurement of nitric oxide release from vascular endothelial cells [J].
Guo, JP ;
Murohara, T ;
Buerke, M ;
Scalia, R ;
Lefer, AM .
JOURNAL OF APPLIED PHYSIOLOGY, 1996, 81 (02) :774-779
[4]   ROLE OF NEUTROPHILS IN MYOCARDIAL-ISCHEMIA AND REPERFUSION [J].
HANSEN, PR .
CIRCULATION, 1995, 91 (06) :1872-1885
[5]   Pharmacological inhibition of epsilon PKC suppresses chronic inflammation in murine cardiac transplantation model [J].
Koyanagi, Tomoyoshi ;
Noguchi, Kenichiro ;
Ootani, Akifumi ;
Inagaki, Koichi ;
Robbins, Robert C. ;
Mochly-Rosen, Daria .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 43 (04) :517-522
[6]  
Kuntscher MV, 2002, PLAST RECONSTR SURG, V109, P2398
[7]  
Lefer AM, 1996, CARDIOVASC RES, V32, P743, DOI 10.1016/0008-6363(96)00073-9
[8]   Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats [J].
Lefer, DJ ;
Scalia, R ;
Campbell, B ;
Nossuli, T ;
Hayward, R ;
Salamon, M ;
Grayson, J ;
Lefer, AM .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (04) :684-691
[9]   Effect of NO synthase inhibition on cardiovascular circadian rhythms in wild-type and eNOS-knock-out mice [J].
Lemmer, Bjoern ;
Arraj, Mahran .
CHRONOBIOLOGY INTERNATIONAL, 2008, 25 (04) :501-510
[10]   LEUKOCYTES AND ISCHEMIA-INDUCED MYOCARDIAL INJURY [J].
LUCCHESI, BR ;
MULLANE, KM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1986, 26 :201-224